These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16721816)

  • 1. Predictive value of initial urodynamic pattern on urinary continence in patients with myelomeningocele.
    Kessler TM; Lackner J; Kiss G; Rehder P; Madersbacher H
    Neurourol Urodyn; 2006; 25(4):361-7. PubMed ID: 16721816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chances of a spina bifida patient becoming continent/socially dry by conservative therapy.
    Knoll M; Madersbacher H
    Paraplegia; 1993 Jan; 31(1):22-7. PubMed ID: 8446444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
    Lemack GE; Frohman EM; Zimmern PE; Hawker K; Ramnarayan P
    Urology; 2006 May; 67(5):960-4. PubMed ID: 16635509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele.
    Kessler TM; Lackner J; Kiss G; Rehder P; Madersbacher H
    Neurourol Urodyn; 2006; 25(7):758-62. PubMed ID: 16986135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clinical or urodynamic parameters predict artificial urinary sphincter outcome in post-radical prostatectomy incontinence?
    Thiel DD; Young PR; Broderick GA; Heckman MG; Wehle MJ; Igel TC; Petrou SP
    Urology; 2007 Feb; 69(2):315-9. PubMed ID: 17320671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.
    Kajbafzadeh AM; Sharifi-Rad L; Baradaran N; Nejat F
    Urology; 2009 Aug; 74(2):324-9. PubMed ID: 19476983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder.
    Khoury AE; Dave S; Peralta-Del Valle MH; Braga LH; Lorenzo AJ; Bägli D
    BJU Int; 2008 Jan; 101(2):223-6. PubMed ID: 17970790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes.
    Trigo Rocha F; Gomes CM; Mitre AI; Arap S; Srougi M
    Urology; 2008 Jan; 71(1):85-9. PubMed ID: 18242371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urological outcome after myelomeningocele: 20 years of follow-up.
    Thorup J; Biering-Sorensen F; Cortes D
    BJU Int; 2011 Mar; 107(6):994-9. PubMed ID: 20860652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary incontinence and voiding dysfunction after radical retropubic prostatectomy (prospective urodynamic study).
    Majoros A; Bach D; Keszthelyi A; Hamvas A; Romics I
    Neurourol Urodyn; 2006; 25(1):2-7. PubMed ID: 16224797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele].
    Lusuardi L; Nader A; Koen M; Schrey A; Schindler M; Riccabona M
    Aktuelle Urol; 2004 Feb; 35(1):49-53. PubMed ID: 14997415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic testing in evaluation of postradical prostatectomy incontinence before artificial urinary sphincter implantation.
    Lai HH; Hsu EI; Boone TB
    Urology; 2009 Jun; 73(6):1264-9. PubMed ID: 19371935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic findings in young men with chronic lower urinary tract symptoms.
    Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
    Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study?
    Sekido N; Hinotsu S; Kawai K; Shimazui T; Akaza H
    Int J Urol; 2006 Oct; 13(10):1276-9. PubMed ID: 17010004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A; Mahboubi AH; Payabvash S
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
    Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
    Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.